Sideris Pharmaceuticals, Inc. — Form D
Sideris Pharmaceuticals, Inc. of BOSTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2013-10-24. The offering totals $32.0M, of which $17.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2013-10-24
- Form: D
- Accession: 0001140361-13-039479
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $32.0M
- Amount sold: $17.0M
- Remaining: $15.0M
- Investors: 6
- Date of first sale: 2013-10-10
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-205211
Issuer
- Name: Sideris Pharmaceuticals, Inc.
- CIK: 0001587658
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2012
- Address: C/O MPM CAPITAL, BOSTON, MA, 02116
- Phone: 617-425-9232
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Ansbert K Gadicke | Director | Boston, MA |
| Douglas K Reed | Director | Durham, NC |
| Kazumi Shiosaki | Director | Watertown, MA |
| Kazumi Shiosaki | Executive Officer | Watertown, MA |
| Thomas Neenan | Director | Lexington, MA |
| Thomas Neenan | Promoter | Lexington, MA |
Other filings by this issuer (1)
More